NSE: CYIENTDLM | BSE: 543933

Expensive Performer

Download real time

485.50 1.65 (0.34%)

44.20% Fall from 52W High

78,744 NSE+BSE Volume

NSE 17 Jul, 2025 3:31 PM (IST)

3,853.1

Market Cap

Market Runner Up

1.0

Beta 1Year

Average volatility

Board Meeting

The next board meeting for Cyient DLM Ltd. is on 22 Jul 2025 for the purpose of Quarterly Results See details

Cyient DLM Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CYIENTDLM, BSE:543933 Cyient DLM Ltd.

Search Inside the pdf :

Cyient DLM Ltd.

25 Apr 2025

485.50

0.34%

Cyient (CYL IN) Q4FY25 Result Update Weak performance,...

Hold: Cyient DLM Ltd.

Prabhudas Lilladhar

the operating performance of the company at the fag end of the quarter. The impact was visible across verticals and geographies (ex-Europe). The management indicated that the softness should continue in the subsequent quarters, however the degree of impact would be lesser than that of Q4. We believe the combination of CYL's structural challenges along with the...

Cyient DLM Ltd. is trading above its 100 day SMA of 452.8

Cyient DLM Ltd.

24 Apr 2025

485.50

0.34%

Cyient DLM (CYIENTDL IN) Q4FY25 Result Update Defense...

Accumulate: Cyient DLM Ltd.

Prabhudas Lilladhar

even after excluding the one off in Q4FY25, CYIENTDL is confident to report 10%+ EBITDA margin in FY26. We have revised TP to Rs546 (Rs692 earlier), based on 30x FY27E earnings and downgrade our recommendation to Accumulate' from BUY'. CYIENTDL defense segment got impacted due to completion of contract from domestic client, with the order book declining 12% YoY to Rs 19bn. However, company remains positive about securing robust orderbook from Q2FY26 onwards mainly from International clients. The management indicated that the contracts secured from Boeing Global Services...

Cyient DLM Ltd. is trading below its 150 day SMA of 492.3

Cyient DLM Ltd.

22 Apr 2025

485.50

0.34%

Slowdown in orders stifles near-term growth visibility

Buy: Cyient DLM Ltd.

Target

Motilal Oswal

Cyient DLM’s (CYIENTDL) 4QFY25 consolidated revenue/EBITDA grew ~18%/51% YoY. EBITDA margins surpassed our estimates, expanding 290bp YoY, led by a favorable product mix, operational efficiencies, and one-offs (~250bp).

Cyient DLM Ltd. has an average target of 744.50 from 3 brokers.

Cyient DLM Ltd.

21 Jan 2025

485.50

0.34%

Slowdown in order flows dampens growth visibility

Buy: Cyient DLM Ltd.

Target

Motilal Oswal

Cyient DLM’s (CYIENTDL) 3QFY25 consolidated revenue/EBITDA grew by ~38%/23% YoY. However, EBITDA missed our estimates as margins declined 90bp YoY due to a high mix of low-margin business (BEL order execution)

Cyient DLM Ltd. has lost -37.93% in the last 1 Year

Cyient DLM Ltd.

11 Dec 2024

485.50

0.34%

CYIENT DLM LTD.

Buy: Cyient DLM Ltd.

Ventura

Navigating the evolution of EMS in India

Cyient DLM Ltd. has an average target of 744.50 from 3 brokers.

Cyient DLM Ltd.

21 Oct 2024

485.50

0.34%

Defense momentum fuels growth trajectory

Buy: Cyient DLM Ltd.

Target

Motilal Oswal

Cyient DLM (CYIENTDL) reported a strong quarter, with revenue growth of ~33% YoY in 2QFY25, led by significant traction in the defense (up 82% YoY) and aerospace (up 20% YoY) verticals.

Cyient DLM Ltd. has lost -37.93% in the last 1 Year

Cyient DLM Ltd.

22 Jul 2024

485.50

0.34%

Strong growth in aerospace and defense drives revenue

Buy: Cyient DLM Ltd.

Target

Motilal Oswal

Cyient DLM (CYIENTDL) reported a healthy quarter, with revenue growth of ~19% YoY in 1QFY25, led by significant traction in the aerospace and defense verticals.

Cyient DLM Ltd. is trading above its 100 day SMA of 452.8

Cyient DLM Ltd.

23 Apr 2024

485.50

0.34%

Revenue growth remains strong

Buy: Cyient DLM Ltd.

Target

Motilal Oswal

Cyient DLM (CYIENTDL) reported another quarter of strong revenue
growth. Its revenue jumped ~30% YoY in 4QFY24, fueled by significant
traction from the Defense (+78% YoY) and Aerospace (+52% YoY) verticals.
However, EBITDA margin contracted 100bp YoY to 10.5%, primarily due to
the increase in SG&A expenses